Corporate news - Gerresheimer

Corporate news

Revenues up 1.9% (3.7% organically) to EUR 1,290.0m Adjusted EBITDA totals EUR 258.5m at constant exchange rates Earnings per share up 6.6% to…
Read more
Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and…
Read more
Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare Growing importance of drug delivery and dosage devices…
Read more
Revenues up 2.2% to EUR 323.9m (+3.2% at constant exchange rates) Adjusted EBITDA with slight improvement on prior-year quarter at EUR 62.1m Net…
Read more
Revenues up 2.6% to EUR 335.4m (6.0% at constant exchange rates) Adjusted EBITDA rises 9.1% to EUR 65.1m (14.1% at constant exchange rates) Net…
Read more
Dividend raised to EUR 0.70 per share Management Board and Supervisory Board given formal approval by large majority Dr. Axel Herberg new member…
Read more
Düsseldorf/Peachtree City (Georgia/USA), March 10, 2014 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry,…
Read more
Third-quarter revenues up 1.8% (+4.5% excluding exchange rate effects), to EUR 316.9m Adjusted EBITDA reaches EUR 61.6m (prior-year quarter: EUR…
Read more
Düsseldorf, April 18, 2013 – A dividend of EUR 0.65 per share was approved at the Annual General Meeting of Gerresheimer AG held today in Düsseldorf.…
Read more

Contact us!

Communication & Marketing
Phone: +49 211 61 81 251
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com